Data suggests that private banks are growing personal loans at a significant pace in order to grab a bigger share of the lucrative market.
Expenses were at Rs 415.03 crore, as compared to Rs 353.36 crore a year ago.
Total income in the quarter came down to Rs 1,206.06 crore from Rs 1,452.84 crore in the same period a year ago.
The company's consolidated income during October-December period increased to Rs 1,503.56 crore from Rs 1,006.93 crore in the year-ago period.
Its total income during October-December 2022 rose to Rs 1,570 crore, from Rs 1,497.78 crore in the year-ago period.
In a statement, SAIL said its crude steel production was at 4.708 Million Tonne (MT) during October-December compared to 4.531 MT a year ago.
The company had clocked a net profit of Rs 52.3 crore in the October-December period of the preceding 2021-22 fiscal, SEIL said in a regulatory filing.
Its total expenses soared to Rs 570.12 crore, compared to Rs 446.39 crore a year ago.
Total income rose to Rs 356.90 crore in the third quarter of this fiscal year from Rs 314.64 crore in the corresponding period of the previous year, the company said in a regulatory filing.
Consolidated revenue from operations stood at Rs 699 crore in the quarter under review as compared to Rs 854 crore in the year-ago period, it added.
Its revenue from operation was flat at Rs 540.12 crore during the quarter under review as against Rs 544.52 crore in the corresponding quarter previous fiscal.
Revenue soared 54 per cent to Rs 219 crore while EBITDA almost doubled to Rs 171 crore.
According to the company filing, Info Edge wrote off Rs 519.93 crore in property tech start-up 4B Networks, led by former Housing.com founder Rahul Yadav.
Consolidated revenue was at Rs 3,463.9 crore, as against Rs 3,173.4 crore, up 9.2 per cent, Glenmark Pharmaceuticals said.
The total income during the quarter was flat at Rs 8.5 crore, Religare Enterprises said in a regulatory filing.
In a statement, the PSU said lower sales volume of alumina during the quarter, higher input costs coupled with global challenging business scenario and volatility have affected the profit margins despite the company registering robust growth in production.
Revenue from operations rose to Rs 1,560 crore in the third quarter as compared to Rs 1,467 crore in the year-ago period, Fortis Healthcare said in a regulatory filing.
The company did not offer an explanation for the decline in its profit but said the quarterly net profit includes Rs 56.8 crore from IPO financing activity.
Its revenue from operations was up 21.47 per cent at Rs 1,561.74 crore during the quarter under review as against Rs 1,285.68 crore in the year-ago period.
Consolidated revenue from operations during the period under review stood at Rs 586.41 crore as compared to Rs 360.12 crore in the corresponding period last fiscal.
The board has also approved raising of Rs 300 crore funds through Qualified Institutions Placement (QIP), subject to necessary approvals.
In the December quarter, total revenue rose to Rs 2,427 crore from Rs 2,101 crore a year ago.
Total expenses increased to Rs 522.31 crore in the October-December quarter from Rs 283.65 crore in the year-ago period.
The company had clocked a PAT (profit after tax) of Rs 107.19 crore during October-December quarter of preceding 2021-22 fiscal, Indian Renewable Energy Development Agency (IREDA) said in a statement.
During the quarter, the company's gross premium rose 12 per cent to Rs 665 crore, while the number of individual policies written increased by 10 per cent.